Impact of pneumococcal conjugate vaccination on hospitalized childhood pneumonia in Taiwan
Journal
Pediatric research
Date Issued
2021-12-22
Author(s)
Abstract
A national 13-valent pneumococcal conjugate vaccine (PCV13) catch-up program among children aged 2-5 years in 2013, before routine infant immunization in 2015, successfully reduced serotype 19A-related invasive pneumococcal diseases in Taiwan. We aimed to investigate its impact on hospitalized childhood pneumonia.
Subjects
COMMUNITY-ACQUIRED PNEUMONIA; US CHILDREN; VACCINES; ADMISSIONS; ETIOLOGY; EMPYEMA
Publisher
SPRINGERNATURE
Type
journal article